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Southern Denmark, Odense, DenmarkABSTRACT A kinetic model of the effect of agonist and anesthetics on ligand-gated ion channels, developed in earlier work, is
further refined and used to predict traces observed in fast-perfusion electrophysiological studies on recombinant GABAA recep-
tors under a wide range of agonist and/or anesthetic concentrations. The model incorporates only three conformational states
(resting, open, and desensitized) but allows for the modulation of the conformational free energy landscape connecting these
states resulting from adsorption of agonist and/or anesthetic to the bilayer in which the protein is embedded. The model is shown
to reproduce the diverse and complex features of experimental traces remarkably well, including both anesthetic-induced and
agonist-induced traces, as well as the modulation of agonist-induced traces by anesthetic, either coapplied or continuously pre-
sent. The solutions to the kinetic equations, which give the time-dependence of each of the nine protein states (three ligation
states for each of the three conformations), describe the flow of probability among these states and thus reveal the kinetic un-
derpinnings of the traces. Many of the parameters in the model, such as the desorption rate constants of anesthetic and agonist,
are directly related to model-independent experimental measurements and thus can serve as a definitive test of its validity.INTRODUCTIONThere is a broad consensus that inhalation anesthetics act by
inhibiting the development of an action potential in postsyn-
aptic membranes, and that they do so by modulating the ac-
tivity of the membrane proteins that mediate synaptic
neurotransmission. Although there is less agreement on spe-
cific protein targets, the most likely candidates are thought
to be postsynaptic receptors, most of which are members
of the cys-loop family of pentameric ligand-gated ion chan-
nels (pLGICs). However, the mechanism(s) by which small
molecules with anesthetic potency influence receptor activ-
ity remain unknown. Indeed, it is not even known whether
the anesthetic effect of many of these molecules occurs
through direct binding to localized sites on receptors, or
indirectly through adsorption to (and modulation of the
physical properties of) the bilayer in which the receptors
are embedded, or perhaps some combination of the two.
The difficulty in determining the molecular mechanism
arises in large part because receptor activity is complex
and incompletely understood. Fast-perfusion electrophysio-
logical studies have explored the response of receptors to a
pulse of their neurotransmitter agonist, which induces a
conformational change that opens transmembrane channels
through which selected ions can flow. (Rapid solution ex-
change provides a good experimental approximation of a
‘‘pulse’’ (boxcar) function, in which agonist concentrationSubmitted October 30, 2014, and accepted for publication December 29,
2014.
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0006-3495/15/03/1081/13 $2.00changes instantaneously from zero to some constant positive
value at the beginning of the pulse, and returns instanta-
neously to zero at the end of the pulse.) For most receptors,
single-channel measurements have revealed that the ion
conductance in its open state(s) appears to be constant.
For a patch containing a large number of receptors, the
measured ion current is thus proportional to the fraction of
channels in conducting states. The resulting current traces
therefore provide, to within a multiplicative constant, the
fraction of proteins in a conducting (open channel) confor-
mation as a function of time. These traces can exhibit a
remarkably complex time-dependence, the features of
which may vary sensitively with agonist concentration.
The degree of complexity increases in the presence of anes-
thetics, which modulate characteristic features of these
traces in a manner that depends sensitively on anesthetic
concentration.
The general class of mechanism by which anesthetics in-
fluence receptor activity can be categorized as either direct
(binding to localized sites) or indirect (bilayer-mediated).
However, neither the discovery of protein sites to which
an anesthetic binds at clinical concentrations, nor (alterna-
tively) an unambiguous determination that clinical concen-
trations of anesthetics modulate physical properties of lipid
bilayers, would in itself provide a mechanistic understand-
ing of anesthesia. Either way, a fundamental understanding
additionally requires development of a detailed kinetic
model that explicitly incorporates anesthetic effects
(whether binding or bilayer-mediated), and that reproduces
the complex kinetics of agonist-induced current traces andhttp://dx.doi.org/10.1016/j.bpj.2014.12.052
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range of both agonist and anesthetic concentrations. To be
of any predictive value, such an approach must also be sus-
ceptible to model-independent experimental verification or
falsification, which can thus serve to distinguish unambigu-
ously between direct binding and bilayer-mediated models
of anesthetic mechanisms. Although this may seem an
obvious goal, a comprehensive kinetic model has not yet
been suggested for a direct binding mechanism of action
of inhalation anesthetics. This is perhaps surprising, given
the current enthusiasm for a binding mechanism, the sophis-
tication of fast-perfusion electrophysiological methods, and
the availability of software through which numerical
solutions can be obtained for classical kinetic schemes
involving standard (Markovian) binding and conformational
transitions.
For various members of the pLGIC family of receptors
(predominantly GABAA and acetylcholine receptors), ki-
netic models have certainly been proposed to rationalize
the experimentally observed response of the receptor to
its agonist. The simplest models of GABAAR kinetics pre-
sume that the protein can exist in one of three conforma-
tional states: resting, open, and desensitized, in which
only the open state conducts ions (1). The agonist interacts
with the protein solely by binding to its pair of equivalent
extracellular sites, which destabilizes the resting state rela-
tive to both the (kinetically favored) open state and the
(thermodynamically favored) desensitized state. Such
models can capture some of the general features of current
traces, such as rapid activation followed by a gradual
decrease in current (desensitization) in the continued pres-
ence of saturating concentrations of agonist. However, it
is well known that they fail to reproduce the temporal
complexity of experimental traces, particularly at high
agonist concentrations (e.g., multiple timescales of desensi-
tization) unless additional conformational states are added
to the kinetic scheme. With the inclusion of such states
and the appropriate adjustment of kinetic parameters, these
kinetic models can indeed reproduce observed traces, albeit
over limited ranges of concentration (2–7). However, aside
from the improbability that a protein requires so many
distinct conformational states for proper function, the value
of such a model is limited, since the existence of those
states cannot be confirmed experimentally. Furthermore,
even with additional conformational states, such models
are not able to reproduce traces over the broadest range
of agonist concentration.
We have previously developed a general kinetic model (8)
in which aqueous solutes (agonist and/or anesthetic) can
adsorb to the bilayer, and thereby modulate the conforma-
tional free energy landscape of the protein. Although the
model includes only the minimal set of three protein confor-
mational states, this study shows that it can nonetheless
reproduce the full range of complex features of electrophys-
iological traces. In brief, the complexity results from theBiophysical Journal 108(5) 1081–1093time-dependence of solute adsorption to the bilayer, which
modulates the rate constants of conformational transitions.
As a first test, the model was shown (8) to provide excellent
fits to data obtained for the special case in which currents
were induced by volatile anesthetics alone (i.e., in the
absence of agonist, which thus greatly simplifies the kinetic
mechanism) in recombinant a1b2g2L GABAA receptors (9).
Although this is a simpler special case, these fits provided
values of parameters, such as bilayer adsorption and desorp-
tion rate constants of these anesthetics, which, in principle,
could be directly compared with independent experimental
measurements, and could thus serve as an unambiguous
test of the model.
The next step is clearly to apply the full kinetic model
developed in (8)—which includes binding of agonist to its
canonical sites as well as adsorption of both agonist and an-
esthetics to the bilayer—to a set of experimental results for
one (or preferably more) receptors. A conclusive test would
require an extensive set of very accurate electrophysiolog-
ical traces, in which concentrations of agonist and anes-
thetic(s) are independently and systematically varied over
a wide range, up to concentrations far in excess of binding
saturation of agonist and clinical values of anesthetics.
Given its importance to the elucidation of anesthetic mech-
anisms, and more fundamentally to the mechanism of the
complex agonist-induced behavior of receptors, it is surpris-
ing that such a comprehensive set of electrophysiological re-
sults simply does not exist in the literature for any one
receptor. Validation of any kinetic model—whether based
on direct binding of anesthetic or bilayer-mediated effects
of both anesthetic and agonist—is extremely difficult in
the absence of such data. Fortunately, however, many of
the defining features of current traces are shared (at least
qualitatively) by related receptor isoforms studied in
different labs; these consistent features thus provide a suffi-
ciently challenging test for any kinetic model. Of course, the
model must not only be capable of reproducing observed
traces, but its assumptions and architecture must be physi-
cally reasonable, and the values of any fitted parameters
must also be susceptible to model-independent experimental
confirmation.
We consider in this study the detailed characteristics of
current traces through GABAA receptors, as these receptors
have been extensively studied by fast-perfusion electro-
physiological methods, and they have the advantage—com-
mon among inhibitory (anion-selective) receptors—that
currents can be induced not only by agonists, but by supra-
clinical concentrations of anesthetics. To provide the most
comprehensive test of the model, we examine predictions
for three general classes of current traces, each over an
extremely wide range of concentrations: anesthetic-induced
(without agonist), agonist-induced (without anesthetic),
and modification of agonist-induced traces by varying con-
centrations of anesthetic, either coapplied or continuously
present.
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The general kinetic model was developed in Cantor et al. (8), hereafter
labeled ‘‘I’’ to which the reader is referred for details; it is summarized in
the next section, as well as in a recent review (10). All references to
numbered equations and figures in Cantor et al. (8) are notated ‘‘I.xx,’’
where xx is the equation or figure number. The subsequent section describes
the further development of the approach, in which we have incorporated a
set of additional approximations, which reduce significantly the number of
independent kinetic parameters. This is followed by descriptions of the
parameter set and methodology.Kinetic model
The protein is assumed to exist in one of three conformational states: X¼ R
(resting), D (desensitized), and O (open); only the open state is conducting.
Conformational transitions among all three pairs of states are allowed; the
desensitized state can thus be accessed fromeither the resting state (branched
desensitization) or open state (linear desensitization). The two agonist bind-
ing sites are assumed to be equivalent, so that a protein in conformationX can
exist in one of three ligation states {A0X, A1X, A2X}, with appropriate sta-
tistical factors in the rate equations of binding and unbinding to account for
the degeneracy of the monoliganded state. The kinetic scheme is shown in
Fig. I.1 (i.e., Fig. 1 in (8)); for convenience, it has been provided as well in
Fig. S1 in the Supporting Materials. The fraction of protein in state X with
i bound agonist molecules is denoted fAiXðtÞ; because the fractions add to
1, the protein distribution is defined by any eight of these nine fractions.
The kinetics of conformational transitions and the binding of agonist to pro-
tein sites are modeled using standard forms for the rate equations, expressed
in terms of fAiXðtÞ, as detailed in Eqs. I.2 and I.3 (i.e., Eqs. 2 and 3 in (8)).
Each conformational state can be interpreted as a local minimum along a
generalized conformational coordinate that describes the protein free en-
ergy landscape, as illustrated in Fig. I.2, and in Fig. 3 in (10). The landscape
changes significantly upon binding of agonist. For example, with no agonist
bound, the lowest free energy minimum is that of the resting state (A0R),
whereas for the diliganded protein, the free energy minima corresponding
to the open and desensitized states (A2O and A2D) are both lower than
that of the resting state (A2R). Of course, the landscape describes not just
the minima, but all points along the trajectories of conformational transi-
tions, including the maxima associated with the barrier (activated complex)
between each pair of conformational states. Free energy landscapes based
on the parameter set used in this work are shown in Fig. S2 for both the un-
liganded and diliganded protein.
Adsorption of solutes (agonist or anesthetic) onto the lipid bilayer of the
postsynaptic membrane alters the physical properties of the bilayer. The
bilayer constitutes an important part of the fluid environment of the protein,
so changes in bilayer physical properties can change the protein free energy,
to a degree that may vary with position on the free energy landscape. The
entire landscape, including the local minima (conformational states) and the
maxima separating them, will thus be modulated nonuniformly by changes
in bilayer properties, i.e., the free energy will change to a degree that varies
with position along the conformational coordinate. Let x represent a gener-
alized conformational coordinate and G(x) the standard free energy land-
scape of the protein, where the standard state () refers to the absence of any
adsorbed solutes. In a Langmuir approximation, let qs represent the frac-
tional bilayer adsorption of solute s (agonist or anesthetic), i.e., the fraction
of its surface density at saturation. The free energy will vary with a sensi-
tivity ls(x) that depends both on location on the conformational landscape
(x) and the identity of the solute. At low adsorption, the change will be pro-
portional to qs, i.e.,
GðxÞ ¼ GðxÞ þ qslsðxÞ: (1)
Consider the effect of adsorption on the kinetics of a conformational tran-
sition AiX/ AiY (i.e., from state X to state Y, with i ligands bound). LetAiXY
z represent the activated complex, at which the free energy reaches a
maximum along the trajectory AiX/ AiY. To reasonable approximation,
the transition rate constant kAiX/AiY depends exponentially on DG
z, the
molar free energy barrier between the initial state (x ¼ AiX) and the acti-
vated complex (x ¼ AiXYz), with
kAiX/AiYfexp
DGzRT; (2)
and
DGz ¼ GAiXYz
 GðAiXÞ ¼ DGz þ qs Dls;AiX/AiY;
(3)
where Dls;AiX/AiY ¼ lsðAiXYzÞ  lsðAiXÞ represents the difference in
sensitivities (to solute s) of the protein in the activated complex and in its
initial state. If Dls;AiX/AiY s 0, then membrane adsorption/desorption
of solute will cause k to vary with qs as in the following:
kAiX/AiY ¼ kAiX/AiY exp
 qsas;AiX/AiY

; (4)
where k represents the standard rate constant (i.e., at qs¼ 0), and we define
a dimensionless sensitivity of the rate constant: as;AiX/AiY ¼
Dls;AiX/AiY=RT. Because adsorption/desorption of solutes does not occur
instantaneously (i.e., qs varies with time), and because the exponential func-
tion can be such a sensitive function of its argument, the rate constants of
conformational transitions are thus strongly time-dependent.
The time-dependence of adsorption, qs(t), is determined in a simple
Langmuir approximation of adsorption/desorption kinetics, given in
Eq. I.7. The equilibrium adsorption of solute at aqueous concentration cs
is thus (Eq. I.9):
qs;eq ¼ csKads;s=ð1þ csKads;sÞ;
where Kads,s ¼ kon,s/koff,s.Additional approximations
The general model contains kinetic parameters that involve binding and un-
binding of agonist to receptor, standard rate constants of transitions among
conformational states for different degrees of ligation, the rate constants of
adsorption/desorption to the bilayer for both agonist and anesthetic, and the
sensitivities (described above) of rate constants of conformational transi-
tions. Thermodynamic constraints reduce the number of independent pa-
rameters somewhat, as described by Eqs. I.12 to I.20. The physical
principles inherent in the approximations of the model lead to additional re-
lationships among both 1) the sensitivities and 2) the standard rate constants
that further reduce the number of independent parameters, as follows.
Sensitivity parameters
Eq. I.18 indicates that the difference in sensitivities of the rate constants of
opposing conformational changes is independent of ligation state:
as;A0X/A0Y  as;A0Y/A0X ¼ as;A1X/A1Y  as;A1Y/A1X
¼ as;A2X/A2Y  as;A2Y/A2X; (5)
where {X,Y} ¼ {R,O}, {O,D}, or {R,D}. These relations are exact, since
they arise from thermodynamic constraints. As noted in Eq. I.19, each of
these differences in the sensitivities of opposing rate constants is propor-
tional to the difference in sensitivities of the free energies of the two states:
as;AiX/AiY  as;AiY/AiX ¼ ðls;AiY  ls;AiXÞ=RT: (6)Biophysical Journal 108(5) 1081–1093
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of a solute s presumably depends on the structural properties of the confor-
mational state (shape, etc.) in the membrane domain. Since the binding of
agonist A to conformational state X is presumed not to affect the structural
properties of state X, it is thus reasonable to assume that the sensitivity of
that state is independent of ligation, i.e.,
ls;A0X ¼ ls;A1X ¼ ls;A2X: (7)
This will presumably remain a good approximation at any point on the pro-
tein free energy landscape; not just at a local minimum (conformational
state), but also at a maximum (activated complex), or anywhere else. The
notation for the minima and maxima can thus be simplified to ls,X and
ls;XYz , respectively. If so, then the difference in sensitivities of two different
points on the protein free energy landscape will also be independent of liga-
tion state. If the two points correspond to a pair of conformational states
{X, Y}, then Eq. 7 simply regenerates the constraints given in Eq. 5 that
arise from thermodynamic considerations. But if the two points on the
free energy landscape correspond instead to a conformational state X and
an adjacent transition state XYz, then since
as;AiX/AiY ¼

ls;XYz  ls;X

RT; (8)
it follows that the sensitivities of the rate constants are also independent of
ligation state, i.e.,as;A0X/A0Y ¼ as;A1X/A1Y ¼ as;A2X/A2Y ¼ as;X/Y (9)
For each solute s, this provides a set of 12 constraints, rather than just the six
constraints given by Eqs. I.18 and I.19. There is one additional constraintrelating opening, linear, and branched desensitization given by Eq. I.20,
so that altogether only 18 – 13 ¼ 5 independent sensitivity parameters
remain for each solute.
Standard rate constants
The rate constants kAiX/AiY are standard state values, in that they describe
the kinetics of conformational transitions in the absence of solute adsorp-
tion to the bilayer. The thermodynamic constraints given by Eq. I.17 (one
for each ligation state) reduce this number from 18 to 15. Unlike the sensi-
tivities, these standard rate constants are strongly affected by ligation state
(increased ligation shifts the equilibrium from the resting to the open and
desensitized states). The equivalence of the two binding sites results in
the two constraints given by Eq. I.15, which is expressed in terms of the
rate constants in Eq. I.16. For example, for the opening/closing standard
rate constants:
kA2R/A2O
kA2O/A2R
kA1O/A1R
kA1R/A1O
¼ k

A1R/A1O
kA1O/A1R
kA0O/A0R
kA0R/A0O
: (10)
Since the two ligand binding sites are equivalent, it is reasonable to assume
further that the binding of a ligand alters the rate constant for a particularconformational transition by a constant multiplicative factor, i.e., indepen-
dent of the number of ligands already bound. In other words, for each tran-
sition X/Y, a coefficient vX/Y is defined such that
vX/Y ¼
kA2X/A2Y
kA1X/A1Y
¼ k

A1X/A1Y
kA0X/A0Y
; (11)
and thus kA1X/A1Y ¼ ðkA0X/A0YkA2X/A2YÞ1=2. This leaves 10 independent
parameters for the standard rate constants: fkA0X/A0Y; kA2X/A2Yg for any
five of the six X/Y transitions. Note finally that the original constraints in
Eq. I.16 are the ratio of the individual constraints for the opposing confor-
mational transitions X/Y and Y/X. These two constraints can now beBiophysical Journal 108(5) 1081–1093reexpressed to relate the agonist dissociation constants Kd,X and Kd,Y for
a pair of states {X, Y}, where Kd,X ¼ ku,X/kb,X, and thus
Kd;O ¼ ðvO/R=vR/OÞKd;R; (12)
and Kd;D ¼ ðvD/O=vO/DÞKd;O: (13)Parameter set
As described above, there are 10 independent parameters for the standard
rate constants, and five independent sensitivity parameters for each solute.
The six agonist binding/unbinding rate constants (kb,X, ku,X; X¼ {R, O, D})
are constrained by the two thermodynamic relations given in Eqs. 12 and
13, leaving four independent parameters. The adsorption (on-) and desorp-
tion (off-) rate constants for each solute (kon,ag, koff,ag; kon,an, koff,an) are un-
constrained. The total number of independent parameters thus depends on
which solutes are present. With both agonist and anesthetic, a total of 28
parameters need be specified; the number is reduced to 21 if only agonist
is present. On the other hand, if only anesthetic is present, then since
only the unligated state of the protein can exist, the diliganded standard
rate constants and binding/unbinding parameters are eliminated, leaving
only 12 independent parameters.
Fortunately, some of these parameters are directly related to specific
characteristics of experimental traces. For example, the rate constants of
binding/unbinding to the resting state {kb,R, ku,R}, the standard rate constant
of opening from the diliganded resting state kA2R/A2O, and the associated
equilibrium constant Kopen,2 ¼ kA2R/A2O=kA2O/A2R are determined
from the dependence on agonist concentration of the shape of the current
rise to its peak at the beginning of the pulse. Also, the fraction of protein
in the open state at equilibrium in the absence of agonist has been estimated
for various GABAA receptors (typically of order 0.01% to 0.1%), which
thus constrains Kopen,0 ¼ kA0R/A0O=kA0O/A0R, and the extent of desensi-
tization at sufficiently high concentrations of agonist (high enough to
ensure that the protein is essentially entirely diliganded, but not so high
as to adsorb significantly to the bilayer) determines Kdeslin,2 ¼
kA2O/A2D=k

A2D/A2O
. The equilibrium constant Kads ¼ kon/koff of bilayer
partitioning (adsorption/desorption) has been measured for various solutes,
including anesthetics. As discussed elsewhere (10), the limited information
available for transport-limited desorption rate constants of small solutes in-
dicates that the range of values of koff is fairly narrow—within an order of
magnitude of 100 s1—for a surprisingly broad range of compounds.
Table 1 lists the parameter values used in the calculations reported in this
article. They were chosen largely to reproduce the features of the current
traces published in a series of papers (9,11–14) on the effects of inhalation
anesthetics such as isoflurane on recombinant a1b2g2L GABAA receptors,
over a broad range of agonist and isoflurane concentrations. Of the 28 pa-
rameters, the 14 constants of agonist binding and standard conformational
transitions (columns 1 to 4 in Table 1) depend only on the protein and
agonist; they are independent of any effects of bilayer adsorption and would
thus need to specified for any model of agonist activation of receptors that
includes both linear and branched desensitization. By contrast, the four con-
stants involving bilayer adsorption {koff,ag, Kads,ag, koff,an, Kads,an} depend
only on the solute (agonist or anesthetic) and the bilayer, i.e., they are inde-
pendent of the protein. Only the 10 sensitivities (as,X/Y) depend both on
the protein and on bilayer-mediated effects. Note that only three of the in-
dependent parameters {Kd,R, Kads,ag, and Kads,an} involve concentrations;
the rest are either first-order rate constants or dimensionless.
An extended version of Table 1, containing additional (derived) parame-
ters is given in Table S1. The effects of various representative levels of so-
lute adsorption on the transition rate constants are shown in Table S2.
Fig. S2 provides corresponding diagrams of the free energy landscapes
for the unliganded and diliganded protein, with and without adsorbed
solutes.
TABLE 1 Values of independent parameters
Kd,R ku,R ku,O ku,D koff,ag Kads,ag
1 koff,an Kads,an
1
167 mM 100 s1 0.40 s1 4.0 s1 40 s1 10 mM 320 s1 2 mM
Kopen,0 Kopen,2 kA0R/A0O k

A2R/A2O
aag,R/O aag,O/R aan,R/O aan,O/R
2.9  104 30 8.1  104 s1 800 s1 6.0 1.0 9.1 2.5
Kdeslin,0 Kdeslin,2 kA0O/A0D k

A2O/A2D
aag,O/D aag,D/O aan,O/D aan,D/O
0.22 1.5 0.84 s1 1.1 s1 0.0 0.5 0.4 10.7
kA0R/A0D k

A2R/A2D
aag,R/D aan,R/D
5.4  103 s1 1.0 s1 6.4 14.4
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The time-dependent distribution of protein states is described by the frac-
tions ffAiXðtÞg. For a given parameter set, these are obtained from numer-
ical solutions of the coupled differential equations given by Eq. I.2. In
earlier work on anesthetic-induced traces (8), fits of the model to the exper-
imental traces of Haseneder et al. (9) for long pulses of the anesthetics iso-
flurane and sevoflurane determined the parameters of the kinetic equations.
For that (zero agonist) case, only three (A0R, A0O, and A0D) of the nine
protein states are populated, so the model simplifies considerably. It was
found that the data could be fit by the model in the absence of any contri-
bution from branched desensitization, i.e., if the desensitized state is only
accessed by linear desensitization from the open state (A0O% A0D). On
the other hand, if access to the desensitized state were restricted to occur
only from the resting state (A0R% A0D), then it was found that some of
the basic qualitative features of the traces could not be reproduced. In the
work presented here, an analogous result was found for the case of
agonist-induced traces (without anesthetic); they could also be fit very
well with no contribution from the branched desensitization pathway
(regardless of ligation), using identical values of the subset of parameters
shared by the two cases. Additionally, for both cases, incorporation of
both branched and linear desensitization resulted in equally good fits, but
with different parameter sets. However, to reproduce the features of all
three cases considered here (anesthetic modulation of agonist-induced
traces as well as anesthetic- and agonist-induced traces) over the broadest
possible range of solute concentrations, it was necessary to include both
the branched and linear desensitization pathways; it could not be achieved
with linear desensitization alone.
The measured current is proportional to the fraction of protein in an
open conformation, irrespective of ligation, i.e., to fOðtÞ ¼ fA0OðtÞþ
fA1OðtÞ þ fA2OðtÞ. Because the numerical solution of the kinetic equations
(Eq. I.2) provides the complete protein state distribution ffAiXðtÞg and its
time derivatives, it gives a complete snapshot of the probability distribution
and of the rate of flow of probability among these states at any moment, and
thus elucidates the predominant kinetic pathways followed under various
agonist/anesthetic conditions, and the origins of many of the characteristics
of the traces. For example, as will be discussed below, it indicates under
which conditions the desensitized state is accessed through the branched
or linear paths, and the pathway followed from the diliganded desensitized
state A2D back to the unliganded resting state A0R upon washout at the end
of a pulse of agonist.RESULTS
Three general types of current traces are considered: 1)
anesthetic-induced (without agonist), 2) agonist-induced
(without anesthetic), and 3) modification of agonist-induced
traces by varying concentrations of anesthetic, either coap-
plied or continuously present. Because different researchershave studied GABAA receptors with a range of different
subunit compositions, and using different electrophysiolog-
ical methods, it is not surprising that published results differ
substantially. We rely principally on a series of papers
(9,11–15) that explored a broad range of concentrations
both of agonist and of various inhalation anesthetics,
including the very important case of anesthetic-induced
traces. For a short pulse of agonist, they (and other groups)
have also examined the effect of different modes of
application of anesthetic: either coapplied with agonist or
continuously present (13,16,17). Since predictions of
bilayer-mediated and binding models of agonist effects
differ substantially at extremely high agonist concentrations
cag, we consider particularly the results of Mercik et al. (18),
who explored this range of concentrations. A set of param-
eter values (Table 1) was determined that reproduces the
features of all of these data. The predicted traces for each
of the three general cases are considered sequentially. For
each, the results are described for different ranges of con-
centrations, and for each concentration range, an overview
of the kinetic underpinnings (the flow of protein probability)
is described. This is complemented by animation software,
provided in the Supporting Material, that dynamically illus-
trates the time-dependent flow of probability among all pro-
tein states in the kinetic scheme. It is run interactively,
allowing the user to vary agonist concentration, anesthetic
concentration, and pulse duration.Anesthetic-induced currents
Fig. 1 a provides the response to a long (1.5 s) pulse of iso-
flurane for different values of anesthetic concentration can as
predicted by the model using the parameters listed in Ta-
ble 1. These traces can be compared with the results of Ha-
seneder et al. (9), who studied the activation of recombinant
a2b2g2L GABAA receptors in response to a 1.5 s pulse of the
volatile anesthetics isoflurane and sevoflurane, each over a
wide range of can. The features of the experimental traces
are well reproduced by the model: specifically 1) the onset
of the pulse and approach to equilibrium, and 2) the deacti-
vation following the end of the pulse (i.e., upon washout of
anesthetic).Biophysical Journal 108(5) 1081–1093
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FIGURE 1 (a) Predicted open fraction fO(t) for a 1.5 s pulse of anesthetic
for a wide range of concentrations: can¼ 0.5 mM (black solid line), 1.0 mM
(black dashed line), 1.5 mM (black dotted line), 2.5 mM (black dot-dashed
line), 3.0 mM (blue solid line), 5.0 mM (blue dashed line), 7.5 mM (blue
dotted line), and 15.0 mM (blue dot-dashed line). (b) Equilibrium confor-
mational distribution as a function of anesthetic concentration can: fO,eq
(solid line), fR,eq (dashed line), and fD,eq (dotted line). Note the different
scales for fO,eq (right ordinate) and for fR,eq and fD,eq (left ordinate). The
shape of the distribution results from the increase in G(R) and the decrease
in G(D) relative to G(O) upon bilayer adsorption of anesthetic. A key
feature is the prediction of a very steep decrease in fO,eq after its maximum
(i.e., for can > can,max z 2 mM) as observed experimentally (9), which is
inconsistent with a mechanism based on anesthetic binding to a channel-
blocking site. To see this figure in color, go online.
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As discussed in detail by Cantor et al. (8), at low can the open
fraction fO ¼ fA0O rises monotonically and slowly to its
equilibrium value fO,eq(can). With increasing can, both the
rate of the initial rise and the value of fO,eq increase, with
fO,eq reaching a maximal value at concentration can,max
that is roughly an order of magnitude larger than the clinical
concentration of isoflurane. For can > can,max, the initial rise
in current continues to accelerate but the approach to the
equilibrium value is no longer monotonic, with the value
of fO,eq decreasing rapidly with increasing can; nearly to
zero at roughly 5can,max, as shown in Fig. 1 b.
This latter observation is very important, as this precipi-
tous drop in fO;eq over only a fivefold increase in concentra-
tion is completely inconsistent with a ‘‘blocking’’Biophysical Journal 108(5) 1081–1093mechanism, i.e., the binding of the anesthetic to a putative
site that blocks the flow of ions through the channel. In addi-
tion, the rate of acceleration of the initial rise with
increasing can is also far greater than would be predicted
by a simple binding model. Haseneder et al. (9) and Hapfel-
meier et al. (13) modeled these current traces by including a
kinetic step of binding to a site that blocks ion flow through
the channel, but a comparison of predicted and experimental
equilibrium currents at can ¼ 15 mM in Figs. 4a and 6b in
Haseneder et al. (9) shows that the agreement is poor at
the highest concentrations.
Even for this relatively simple case (no agonist), the flow
of protein probability is complex. Initially, almost all of the
protein is in the resting state, with extremely low rate con-
stants (and thus negligibly slow kinetics) of the conforma-
tional transitions to either the open or desensitized state;
both are of order 103 s1. Upon introduction of anesthetic
in the aqueous phase (assuming rapid solution exchange),
equilibration with the bilayer occurs on a timescale of order
(koff,anþ cankon,an)1. The predicted desorption rate constant
for isoflurane is high enough (koff,an ¼ 320 s1) that the
approach to adsorption equilibrium is essentially complete
in less than 10 ms. Because the values of aan,R/O ¼ 9.1
and aan,R/D ¼ 14.4 are negative, anesthetic adsorption
significantly accelerates both opening (A0R / A0O) and
branched desensitization (A0R/ A0D), but to a far greater
extent for the latter than the former. Except at high can,
which is considered below, the increase in these transition
rate constants from their values in the absence of anesthetic
to their equilibrium values at can is essentially complete
before the resulting flow of protein probability has begun,
so the two conformational transitions occur essentially un-
der the influence of the rate constants at equilibrium adsorp-
tion. For the reverse processes (A0D/ A0R and A0O/
A0R), since the magnitudes of both aan,O/R (¼ 2.5) and
aan,D/R (¼ þ3.3) are relatively small, the rate constants
of both of these reverse processes change far less upon
adsorption of anesthetic than do the rate constants for
A0R/ A0D and A0R/ A0O. The equilibrium thus shifts
from the resting state toward both the open and desensitized
states, but unequally, increasingly favoring the desensitized
state at higher can. With increasing can, the increase in
Kopen;0ð¼ kA0R/A0O=kA0O/A0RÞ results in the development
of a small current, but the concomitant, and far larger
increase in Kdesbr;0ð¼ kA0R/A0D=kA0D/A0RÞ causes an
increasing fraction of protein to go directly to the desensi-
tized state.
As can reaches and exceeds can,max, branched desensitiza-
tion becomes so rapid that it competes with adsorption, and
thus the flow of protein probability begins before kA0R/A0D
has reached its equilibrium value. The result is that the
initial flow into the open state over the first few milliseconds
generates an open fraction the exceeds its equilibrium value:
the ultimate rise of kA0R/A0D to its equilibrium value re-
duces fR nearly to zero, inducing a net flow from A0O to
ab
FIGURE 2 Predicted open fraction fO(t) for a 1.5 s pulse of agonist over a
wide range of concentrations (expressed relative toKd,R¼ 167 mM) in equal
multiplicative increments of 101/3 ¼ 2.154. (a) cag/Kd,R ¼ 0.01 (black line),
0.02154 (black dashed line), 0.04642 (black dotted line), 0.1 (black dot-
dashed line), 0.2154 (blue line), 0.4642 (blue dashed line), 1 (blue dotted
line), 2.154 (blue dot-dashed line), and 4.642 (red long dashed line).
(b) cag/Kd,R ¼ 4.642 (red long dashed line), 10 (black line), 21.54 (black
dashed line), 46.42 (black dotted line), 100 (black dot-dashed line), 215.4
(blue line), 464.2 (blue dashed line), and 1000 (blue dotted line). To see
this figure in color, go online.
Mechanism of Anesthesia: Kinetic Analysis 1087A0D via the A0R state, i.e., A0O/ A0R/ A0D. The time-
scale of flow through these two sequential steps is deter-
mined by the slower rate constant (kA0O/A0R). Because
aan,O/R < 0, kA0O/A0R increases with can, and the decrease
of current (after it passes through its maximum near the
beginning of the pulse) to its equilibrium value occurs
more rapidly with increasing can.
Deactivation
As observed experimentally, a ‘‘rebound’’ current is pre-
dicted to occur within a few tenths of a second uponwashout,
the magnitude of which (unlike the equilibrium reached dur-
ing the pulse) increases monotonically with increasing can; it
approaches a maximum at concentrations not much higher
than can,max. The rapid washout of anesthetic (on the submil-
lisecond timescale) causes desorption of anesthetic from the
bilayer, which occurs on the timescale of a few milliseconds
(koff,an ¼ 320 s1) as discussed above. At lower levels of
bilayer adsorption, the conformational transition rate con-
stants are sufficiently low that they occur on a much slower
timescale than anesthetic desorption, and thus the relaxation
back to the zero-absorption equilibrium is well described as
occurring under the influence of the standard (zero-absorp-
tion) rate constants kA0X/A0Y. For low can, fD,eq is small, so
the dominant process upon washout is A0O / A0R, and
there is thus no rebound peak. At higher can, an increasing
fraction of protein is in the A0D state at the end of the pulse,
and it is the return from A0D to A0R via A0O, i.e., A0D/
A0O / A0R, that is responsible for the rebound current.
Because kA0D/A0R (z85 s
1) >> kA0D/A0O (z3.8 s
1),
the dominant path out of the A0D state is directly to A0R,
so even if all the protein is in the A0D state at the beginning
of washout, the rebound peak remains small (fO z 0.03).
The height of the rebound peak thus varies with fD,eq, which
in turn is a very strong function of can, as shown in Fig. 1 b.
The peak in the rebound is reached in a time determined by
the rate of depletion of A0D: as fD drops and fO rises, the
rate of the A0D / A0O step decreases compared with
A0O/ A0R, and the subsequent decay of the rebound peak
occurs on a timescale determined by kA0O/A0R z 2.8 s
1.Agonist-induced currents
Current traces evoked by a long pulse of agonist have been
obtained experimentally for GABAA receptors, although
generally only for a limited range of agonist concentrations.
Although the details vary among experimental groups, the
dependence of the qualitative features of these traces on
cag are reasonably consistent and are reproduced by the pre-
dicted traces as shown in Fig. 2. Since Kd,R (the agonist
dissociation constant for the resting state) varies widely
among GABAA receptor isoforms, values of cag are ex-
pressed in terms of Kd,R. These features are described below,
for progressively higher cag; they are readily interpreted in
the context of our kinetic model.Very low cag
Note first that the binding affinity is predicted to bemore than
two orders ofmagnitudeweaker for the R state than for either
the O or D states. Upon agonist binding, the O state is kinet-
ically favored (kA2R/A2O[k

A2R/A2D
or kA2O/A2D), but the
D state is thermodynamically favored (Kd,D< Kd,O Kd,R).
Currents begin to be observed for cag ~10Kd,O. For suffi-
ciently low cag (~50Kd,O) such that the current reaches no
more than perhaps 20% of its maximum value, little func-
tional desensitization is observed: fO rises monotonically
and slowly to its steady-state value. This plateau arises
from sequential kinetics: upon binding of the first agonist
molecule to the R state (A0R þ A/ A1R), the subsequent
shift in conformational distribution toward the desensitized
state is essentially entirely a slow transfer in two parts:
A1R/A2O/A2D. (The direct path fromR toD, branchedBiophysical Journal 108(5) 1081–1093
1088 Lee et al.desensitization, is sufficiently slow that it makes no appre-
ciable contribution.) The predominant path for the first part
(A1R/A2O) depends on the details of the parameter values,
and can favor either A1R þ A / A1O þ A / A2O or
A1R þ A/ A2R/ A2O.
Note that although fO reaches its steady-state value within
~0.5 s, the system has not yet reached equilibrium. Because
the rate constants of linear desensitization and resensitiza-
tion are both small, the net transfer from A1R to A2D is
slow. Thus, it takes far longer to attain the equilibrium
values of the fractions of protein in all nine of the conforma-
tional/ligation states than it does to reach the steady-state
current.
cag ~ Kd,R
Slow desensitization begins to be observed on a single time-
scale as cag is increased (but still sufficiently less than Kd,R
such that the peak current is well below its maximum value).
The extent of desensitization increases with cag, correlating
with an increase in the fraction in the open state at its peak.
With increasing cag, as the value of the peak current reaches
its maximum, desensitization remains slow and well
approximated by a single exponential. Over this range of
concentrations, the observed desensitization is entirely a
result of a transition from the O to the D state, predomi-
nantly in the diliganded form at higher cag. Also, with
increasing cag the peak current is reached increasingly
rapidly, indicating that binding of a pair of ligands to the
R state (rather than the subsequent A2R/ A2O step) re-
mains rate-limiting.
Deactivation is complex. At the end of the pulse, almost
all of the protein is in either the A2O or A2D states; we
consider their fates separately. A2O is straightforward: the
dominant path is A2O / A2R / 2A þ R. A2D is more
complex: unbinding of the first ligand (A2D/ A þ A1D)
is predicted to dominate both of the conformational transi-
tions (A2D / A2O or A2D / A2R), whereas A1D un-
dergoes both further ligand unbinding and A1D / A1O
(/ A1R) at competitive rates. As a result, although the
decay of fA2OðtÞ is approximately exponential, fA1OðtÞ rises
through a small maximum and then decays (more slowly),
so that fO(t) is not well fit by a single exponential during
deactivation.
cag > Kd,R
An initial fast component of functional desensitization is
observed, the extent of which increases with cag at values
well in excess of Kd,R. The subsequent slow desensitiza-
tion has time constant similar to that observed at lower
cag. In the context of our model, the decrease in fO asso-
ciated with the fast component of desensitization is not
caused by an increase in fD, but rather by a shift in the
A2R % A2O equilibrium back from the open to the
resting state, i.e., an increase in fR. This reequilibration re-
sults from bilayer adsorption of agonist, which alters theBiophysical Journal 108(5) 1081–1093rate constants of opening and closing unequally: opening
is slowed (aag,R/O z 6) with little effect on closing
(aag,O/R z 1). At these saturating concentrations of
agonist, the adsorption-induced changes in rate constants
occur on a timescale that is significantly slower than the
rapid initial rise to the peak current, which follows the
sequential mechanism 2A þ R / A þ AR / A2R %
A2O. The timescale of binding is of order (cagkb,R)
1,
whereas the timescale of equilibration of the final pair
of reversible opening/closing steps is of order
ðkA2R/A2O þ kA2O/A2RÞ
1zkA2R/A2O
1. Thus, for cag <
kA2R/A2O=kb;R, binding is rate-limiting, whereas for
cag > k

A2R/A2O
=kb;R, channel opening is rate-limiting.
So, in this concentration range (particularly at higher
cag) the formation of the peak occurs in a few millisec-
onds, which is an order of magnitude faster than the pre-
dicted timescale of equilibration of agonist adsorption:
(koff,ag þ cagkon,ag)1 z koff,ag1 ¼ 0.025 s. The peak cur-
rent is thus reached before effects of adsorption become
significant.
For many GABAA receptors, the timescale of the slow
component of functional desensitization has been observed
to remain fairly independent of cag (4,5,15) even as cag is
raised to values at which significant fast desensitization
occurs (resulting, in the context of our kinetic model,
from bilayer adsorption of agonist). The rate of slow
desensitization is determined by kslow des ¼ kA2O/A2D þ
kA2D/A2O. Because both of these rate constants are little
changed from their standard values, the corresponding sen-
sitivities, aag,O/D and aag,D/O, must be zero, or nearly
so. In other words, the part of the free energy landscape
connecting the O and D states is unaffected by agonist
adsorption.
Deactivation is more complex than at the somewhat lower
concentrations described in the previous section (binding
saturation, but without adsorption) because of the modula-
tion of rate constants during the first few hundredths of a
second of washout, as agonist desorbs from the bilayer:
this is the origin of the steep initial decay.
cag >> Kd,R
Adsorption of agonist to the bilayer occurs on a timescale
(cagkon,ag)
1. At extremely high values of cag, significant
adsorption thus occurs before equilibration of A2R and
A2O. Since adsorption of agonist slows the A2R / A2O
transition (while slightly accelerating the A2O/ A2R tran-
sition) the equilibrium shifts toward the closed state, and the
peak open fraction thus decreases with increasing cag. The
onset of this effect has been observed by various groups
that have explored current traces at high cag (4,15), but
most strikingly by Mercik et al. (18) who obtained traces
in response to agonist concentration in the 10 to 100 mM
range. This mechanism also predicts the observed reduction
in the equilibrium open fraction fO,eq (i.e., after slow desen-
sitization is complete).
ab
FIGURE 3 Predicted open fraction fO(t) for a 1.5 s pulse of coapplied
agonist and isoflurane. (a) cag ¼ 0.1Kd,R ¼ 16.7 mM; can ¼ 0 mM (black
line), 0.15 mM (black dashed line), 0.3 mM (black dotted line), 0.5 mM
(black dot-dashed line), 0.75 mM (blue line), 1.0 mM (blue dashed line),
1.25 mM (blue dotted line), 1.6 mM (blue dot-dashed line), 2.2 mM (red
line), 3 mM (red dashed line), and 5 mM (red dotted line). (b) cag ¼
6Kd,R ¼ 1.0 mM; can ¼ 0 mM (black line), 0.2 mM (black dashed line),
0.7 mM (black dotted line), 1.6 mM (black dot-dashed line), 3 mM (blue
line), 6 mM (blue dashed line), and 15 mM (blue dotted line). To see this
figure in color, go online.
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currents
The effect of anesthetics on the response to a pulse of
agonist of duration t has most commonly been explored
in one of two general protocols: coapplication of the two
solutes (i.e., can ¼ 0 for t < 0 and t > t) or in the continuous
presence of anesthetic at concentration can, i.e., before, dur-
ing and after the agonist pulse. Predicted traces of both types
are considered next.
Coapplied anesthetic
Various concentration ranges of agonist and the anesthetic
isoflurane (as well as sevoflurane, xenon and nitrous oxide)
have been explored (11–14,19).
For the very low agonist concentrations discussed in the
section ‘‘Very low cag’’ above (i.e., for which the peak cur-
rent is no more than 20% or so of the maximum, and the cur-
rent rises monotonically to its steady-state value),
coapplication of the anesthetic isoflurane has multiple ef-
fects, as shown in Fig. 3 a for cag ¼ Kd,R/10 ¼ 16.7 mM.
As can is increased, the peak current increases and is reached
more rapidly, and slow desensitization begins to be
observed. At this low agonist concentration, the maximum
in the peak current occurs at can ~ 0.75 mM. With further in-
crease in can, the peak current drops but continues to be
reached more rapidly; the extent and rate of desensitization
are predicted to increase as well. By canz 5 mM, the desen-
sitization has become extremely fast. As was the case for the
anesthetic-only traces described earlier, a rebound current
upon washout is predicted. This overall behavior agrees
with observations for isoflurane (11) and sevoflurane (14).
The acceleration to the peak and initial increase in its
magnitude arise largely from the rapid increase in
kA2R/A2O with increasing can. At higher can, the decrease
in the peak is due largely to the enormous acceleration of
branched desensitization (A2R / A2D), whereas the in-
crease in extent of desensitization arises largely from the
very positive value of aan,D/O, which shifts the A2O %
A2D equilibrium toward the D state.
At higher cag corresponding to binding saturation (cag >
Kd,R), an example of which is shown in Fig. 3 b, the effect
of increasing can is predicted to differ somewhat from its ef-
fect at lower cag. The can-dependence of the rebound current
is similar to what is predicted at subsaturating cag. Both the
rate and the extent of desensitization increase with can; the
peak open fraction, which is large at low can, decreases
significantly at sufficiently high can. Although two of the ef-
fects of the increasing can—the increased extent of desensi-
tization and decreased initial peak—agree with observations
for isoflurane and sevoflurane (11,14), the shape of the pre-
dicted desensitization differs significantly from some of the
experimental traces. For example, in the experimental traces
in Fig. 1 in Neumahr et al. (11), and Fig. 3 in Hapfelmeier
et al. (14), increasing can results in growth of a fast initialcomponent to desensitization, but does not significantly
alter the time constant of slow desensitization. In contrast,
the model does not predict the appearance of a fast compo-
nent but predicts a gradual acceleration in the overall rate of
desensitization. We note that other experimental results are
in closer agreement to the predictions of our model; for
example, a study on isoflurane effects on GABA channels
in crayfish (20) does exhibit a gradual increase in the rate
of desensitization with increasing can, at cag ¼ 10 mM,
without the development of a fast component.
Given these differences, it is important to consider the
origin of the predicted acceleration in desensitization, i.e.,
in the net flow of probability from A2O to A2D. It arises
because anesthetic adsorption shifts the predominant
pathway from direct (A2O / A2D) to indirect (A2O %
A2R / A2D.) Consider the indirect pathway: at low can,
kA2R/A2Dzk

A2R/A2D
is small, and the prior quasi-equilib-
rium of the two opposing faster steps A2O% A2R stronglyBiophysical Journal 108(5) 1081–1093
1090 Lee et al.favors A2O, so the overall rate constant for the indirect
pathway is kindirectzðkA2O/A2R=kA2R/A2OÞkA2R/A2D z
.03 s1, i.e., it makes negligible contribution to desensitiza-
tion. So, in the absence of anesthetic adsorption, desensiti-
zation is governed by the direct route, since
kdirectzkA2O/A2D þ kA2D/A2O[kindirect. Adsorption of
anesthetic results in acceleration of A2R/ A2D (aR/D ¼
14.4) and A2R / A2O (although to a lesser degree;
aR/O ¼ 9.1), the net effect of which is an increase in
kindirectzðkA2O/A2R=kA2R/A2OÞkA2R/A2D that ultimately ex-
ceeds kdirect, the indirect route thus becoming the dominant
pathway of desensitization.
Fig. 4 compares traces evoked by coapplied agonist and
isoflurane at extremely high can (¼ 15 mM) as a function
of cag. The size of the rebound peak increases from ~0.03
at cag ¼ 0 to ~0.09 at cag ¼ 5 mM and remains at this value
with increasing can. This increase in peak height occurs over
a narrow range of very low (submicromolar) concentrations.
The peak shape, and the concentration at which its height in-
creases (~0.1 mM) is in agreement with experimental traces,
as seen in Fig. 3B in Hapfelmeier et al. (12). However, the
magnitude of the predicted increase in the rebound peak is
significantly less than observed experimentally.
This growth of the rebound peak is readily understood in
the context of the model. At the end of the pulse, virtually all
of the protein is in the D conformation. For cag < Kd,R, it is
predominantly unliganded, whereas for cag > Kd,R, it is di-
liganded. Regardless of ligation, anesthetic desorption oc-
curs on a faster timescale (koff,an ¼ 320 s1) than either
agonist dissociation or conformational transitions from theFIGURE 4 Predicted open fraction fO(t) for a 1.5 s pulse of coapplied
agonist and isoflurane; all at the same extremely high anesthetic concentra-
tion (can ¼ 15 mM) but with varying (extremely low) agonist concentra-
tions: cag ¼ 0 mM (black line), 0.02 mM (black dashed line), 0.04 mM
(black dotted line), 0.08 mM (black dot-dashed line), 0.15 mM (blue line),
0.3 mM (blue dashed line), 0.6 mM (blue dotted line), 1.25 mM (blue dot-
dashed line), 2.5 mM (red line), 5 mM (red dashed line), and 100 mM (brown
line). The rebound peak reaches its maximum at ~5 mM. As is evident in the
predicted trace at cag ¼ 100 mM, an initial peak current is predicted to
develop (with no effect on the rebound) and continues to grow as cag is
further increased (not shown), as observed experimentally (e.g., see
Fig. 3B in 12). To see this figure in color, go online.
Biophysical Journal 108(5) 1081–1093AiD state. The path back from AiD to A0R thus occurs
largely under the influence of the standard rate constants.
For the unliganded case (as discussed earlier for anes-
thetic-induced traces), upon washout, the path back from
A0D to A0R is predominantly via the direct route, because
kA0D/A0Rðz85 s1Þ[kA0D/A0Oðz3:8 s1Þ, and thus the
rebound peak is small (fO,peakz 0.03). However, for the di-
liganded case the other processes dominate, because
kA2D/A2Rð¼ 0:022 s1Þ is so small. The higher value of
fO,peak (z0.09) arises largely from two routes to the open
state: A2D / A2O and A2D / A1D þ A / A1O. The
peak remains small in absolute terms, however, because
other paths from A2D to A0R that do not involve the open
state still prevail overall, largely through A2D / A1D þ
A/ A1R þ A/ A0R þ 2A, or A2D/ A0D þ 2A/
A0Rþ 2A. The timescale of the decay is determined largely
from the closing transitions AiO/ AiR; because there are
significant contributions from all three ligation states (i ¼ 0,
1, 2), with rate constants spread from 2.8 s1 to 26.7 s1, the
decay is not well fit by a single exponential.
Continuous application of anesthetic
All the cases discussed above involve coapplication of anes-
thetic with agonist during the pulse. However, it is important
to examine as well the effect of the continuous presence of
an anesthetic (i.e., before, during and after the agonist pulse)
on the response of GABAA receptors to a very short pulse of
agonist at saturating concentrations. Aside from providing
an additional test of the model, the latter protocol far
more closely mimics the effect of anesthetics on inhibitory
postsynaptic currents. Two general trends are typically
observed for volatile anesthetics such as isoflurane
(13,16,17; R. Haseneder, unpublished data) although the de-
tails vary significantly with GABAA subunit composition
(17). With increasing isoflurane concentration 1) the initial
peak current remains approximately constant up to clinical
concentrations (MAC), beyond which it drops rapidly, and
2) the timescale of deactivation lengthens, even at very
low can, reaching a maximum at ~1 mM z 3 MAC
(17,21). These two trends have opposing effects on the total
ion flow Q (integrated current), which thus rises from its
value in the absence of anesthetic to a maximum at supra-
clinical concentrations and decreases thereafter (21). Traces
predicted from the kinetic model are shown in Fig. 5 a for a
short pulse at saturating cag, over a broad range of anesthetic
concentrations. The total ion flow relative to its value in the
absence of anesthetic, Q(can)/Q(0) is graphed in Fig. 5 b,
along with the value of the peak open fraction relative to
its value in the absence of anesthetic, fO,peak(can)/fO,peak(0).
In good agreement with the experimental results cited
above, the slowing of deactivation is already evident at clin-
ical concentrations of anesthetic. The total ion flow thus
rises with can, increasing by a factor of two at can z
1 mM, although the peak current is beginning to decrease.
ab
FIGURE 5 (a) Response to a short pulse (10ms) of agonist (cag¼ 10Kd,R¼
1.67mM), for varying continuous concentration of anesthetic: can¼ 0 (black
line), 0.3mM (black dashed line), 0.9mM (black dotted line), 1.5mM (black
dot-dashed line), 1.8 mM (blue line), 2.1 mM (blue dashed line), 2.7 mM
(blue dotted line), and 3.6 mM (blue dot-dashed line). (b) Solid curve,
Q(can)/Q(0): dependence of total ion flow (integrated current) on can, relative
to total ion flow for can¼ 0. Dashed curve, fO,peak(can)/fO,peak(0): dependence
of peak open fraction on can, relative to peak open fraction for can¼ 0. To see
this figure in color, go online.
Mechanism of Anesthesia: Kinetic Analysis 1091With further increase in can, the peak current drops dramat-
ically. In the context of the model, the reduction in peak cur-
rent results from the anesthetic-induced shift in the
equilibrium between the A0R and A0D states (prior to the
agonist pulse) as evident in Fig. 1 b. In the range of roughly
1 to 2 mM, although the peak current is reduced, the total
ion flow is still larger than in the absence of anesthetic.DISCUSSION
Approximations
The effect of solute adsorption on the free energy landscape
is modeled using two simplistic approximations. In the
Langmuir approximation, the partitioning between
the aqueous and bilayer phases is quantified by treating
the bilayer essentially as a single (effectively two-dimen-sional) unstructured layer onto which solutes adsorb, with
adsorbed molecules interacting only through excluded vol-
ume. The quality of this approximation is likely to worsen
with increasing surface densities, both because solutes
may adsorb over a range of depths in the bilayer, with
different kinetic and thermodynamic characteristics, and
because there may be strong interactions among adsorbed
solutes. The second approximation is that the effect on the
free energy landscape of an adsorbed solute is linear in its
surface density (Eq. 1), which may be inaccurate if adsorp-
tion alters the physical properties of the bilayer itself.
Although valid at low adsorption, both of these approxima-
tions are likely to become increasingly inaccurate at high
levels of adsorption. Unfortunately, it is not yet possible to
improve on these approximations, because relevant experi-
mental data (such as the bilayer adsorption isotherm of
each solute) are not presently available.Parameter set
The parameters were chosen to reproduce reasonably well a
broad range of electrophysiological traces. Although we
found no evidence of any other set of parameters that could
provide such broad qualitative agreement, a comprehensive
search to eliminate such possibilities would be virtually
impossible. However, the important conclusion is that it is
indeed possible to reproduce the full range of features of
these traces using this model, and that some of the key pa-
rameters, such as koff,ag and koff,an, are directly related to
model-independent experimental measurements, and could
thus serve as a definitive test of the model. Although the
values of bilayer desorption rate constants for isoflurane
and GABA have not been reported, the predicted values,
koff,isoflurane z 320 and koff,GABA z 40, certainly fall in
the range (10 to 1000 s1) of the compounds for which
transport-limited desorption rate constants have been ob-
tained or estimated, as discussed elsewhere (10).
It is useful to examine patterns among the values of the
predicted sensitivities, as,X/Y. For three of the six transi-
tions (O/D, O/R, and D/R) the magnitudes of the sen-
sitivities are very small, both for agonist and anesthetic. On
the other hand, the sensitivities are of large magnitude for
both R/O and R/D, although of opposite signs for the
two solutes: negative for isoflurane and positive for
GABA. Only for as,D/O, is there a significant difference
in the magnitude for agonist and anesthetic. These correla-
tions could perhaps be interpreted if it were known which
bilayer property might be responsible for coupling of bilayer
composition to changes in protein free energy, and how that
property depends on the identity of the adsorbed solute. If
agonist and anesthetic have closely related effects on this
property (although perhaps to a different degree per mole
fraction of solute in the bilayer), then the values of the sen-
sitivities might be expected to scale by a single multiplica-
tive constant. For example, it has been suggested (22,23)Biophysical Journal 108(5) 1081–1093
1092 Lee et al.that it is the depth-dependent distribution of lateral pressures
within the bilayer that couples to the protein free energy
landscape. Anesthetics reside predominantly near the
aqueous interfaces, where they increase lateral pressures, re-
sulting largely from excluded volume effects, and thus
decrease lateral pressures in the bilayer interior; this results
in an increase in lipid area and a decrease in bilayer thick-
ness. If, when adsorbed to the bilayer surface, agonists
such as GABA or glycine interact principally through elec-
trostatics and hydrogen bonds to lipid head groups, they
may well reduce inter-head group repulsions, and thus
reduce the lateral pressure in that region. If so, then the ef-
fects of anesthetics and agonist on the free energy landscape
would be expected to have opposite signs, resulting in oppo-
site signs of aag,X/Y and aan,X/Y, as predicted in the ki-
netic analysis.
In light of the relatively large number of parameters in our
kineticmodel, it is useful to consider theminimumnumber of
parameters that would be required for the alternative
approach, i.e., a direct binding kinetic scheme, in which
both anesthetic and agonist interact with the receptor only
by binding to specific sites. As noted earlier, 14 of the 28 pa-
rameters in our model—four ligand unbinding/binding and
10 standard rate constants of conformational transitions—
depend only on the protein and the binding of its agonist,
and would thus need to be specified for any three-state model
of receptors that includes both linear and branched desensiti-
zation. Inclusion of additional conformational states in the
scheme—necessary to reproduce key features of agonist-
induced traces, such as multiple timescales of desensitiza-
tion—would require a minimum of five more parameters
per additional state,without yet having considered the effects
of anesthetics. Even for the simplest case in which an anes-
thetic binds only to a single site on the receptor, specification
of a minimum of 12 additional rate constants would be
required for the three-state system (26 parameters, total)
and 20 additional constants for the four-state system (34, to-
tal) as illustrated by the representative scheme in Fig. S3.
However, even the latter would almost certainly be insuffi-
ciently robust to account either for agonist-only behavior,
or for its modulation by anesthetics, for two reasons. First,
as discussed in the introduction, kinetic models of agonist-
induced currents (2–7) have typically required two additional
desensitizated states (and often additional open states) to
reproduce experimental traces. Second, anesthetics are
known to affect current traces over a significantly larger
range of concentrations than can be accounted for by a single
binding site, so any truly comprehensive binding model
would require multiple anesthetic binding site(s) of signifi-
cantly different affinities; the same can be argued for agonist
as well. The total number of parameters for a binding model
that could account for the full range of features of agonist-
induced, anesthetic-induced and anesthetic modulation of
agonist-induced traces would thus be vastly in excess of the
28 required in our kinetic model.Biophysical Journal 108(5) 1081–1093What can be concluded from this study of the kinetic
mechanism of volatile anesthetic modulation of ion channel
activity? Recent studies (24) have indeed identified various
locations in which an inhalation (desflurane) and an intrave-
nous (propofol) anesthetic have co-crystallizedwith prokary-
otic members of the pLGIC family, generally interpreted as
providing strong support in favor of a direct binding mecha-
nism of their anesthetic action. However, binding affinities
(and thus their potential relevance to anesthesia) have not
been measured for these sites. More generally, identification
of such sites doesn’t rationalize the Meyer-Overton correla-
tion over the remarkably broad range of molecular character-
istics (size, polarity, shape, flexibility, etc.) of inhalation
anesthetics or its well-known exceptions. With regard to
these exceptions—most notably the lack of anesthetic po-
tency of nonimmobilizers—it should be noted that results
of the essential negative control experiment, co-crystalliza-
tion of the receptor with a nonimmobilizer, have not been re-
ported. Additionally, within the context of a bindingmodel, it
seems difficult to explain the remarkably narrow range of
sensitivities to a given anesthetic within the human popula-
tion: what is the essential process imitated by anesthetics
with such minimal molecular specificity that generates
such enormous selection pressure? One plausible idea that
has been suggested (25) is that the small cavities ubiquitous
to many membrane proteins may be essential to facilitate
conformational changes that involve (for example) motions
of adjacent alpha helices in transmembrane bundles; by occu-
pying these sites, which could presumably accommodate a
wide range of small molecules, anesthetics could impede
these motions and thereby influence protein function. How-
ever, at least for GABAA receptors, the effect of anesthetics
in electrophysiological studies, as modeled in this work, is
to accelerate conformational transitions, as has been dis-
cussed elsewhere (8). Also, although this suggestion could
certainly account for the breadth of molecular characteristics
among anesthetics, it does not rationalize theMeyer-Overton
correlation of anesthetic potency with bilayer partitioning, if
the sizes and shapes of these cavities are not critical for
endogenous function.
In any case, no kinetic model in which agonist and anes-
thetics interact with receptors entirely through binding to
localized sites, has yet been proposed that can reproduce
the full range of effects of anesthetics (over a broad range
of anesthetic and agonist concentrations) on electrophysio-
logical traces; this is not surprising in the context of the
above discussion. By contrast, the kinetic model discussed
in this article can not only reproduce the diverse features
of electrophysiological traces (and does so with only three
protein conformational states) but involves key parameters
that can be determined through model-independent experi-
mental measurements. And as discussed elsewhere (10), in
the context of the bilayer lateral pressure profile it not
only explains the Meyer-Overton correlation but it correctly
predicts known exceptions, such as the cutoff in potency in
Mechanism of Anesthesia: Kinetic Analysis 1093long-chain n-alkanols (26), and predicted the anesthetic po-
tency of long-chain polyhydric alkanols—unexpected in the
context of a binding model, given the very large volume of
those compounds—that was subsequently demonstrated
experimentally (27). Finally, since details of temporal mod-
ulation of receptor activity—desensitization and deactiva-
tion—appear to be important (or perhaps even essential)
for proper protein function, if these characteristics result
from (nonspecific) adsorption of neurotransmitter to the
bilayer, then the model provides a plausible explanation of
the strong apparent selection pressure for correct anesthetic
sensitivity (10,28), and predicted that noncognate neuro-
transmitters would significantly modulate receptor activity,
as subsequently demonstrated experimentally (29).SUPPORTING MATERIAL
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